RSBN1L
Lysine-specific demethylase RSBN1L
Also known as: FLJ42526, FLJ45813, MGC71764, RSBNL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PCB5
- Gene
- RSBN1L
- Ensembl
- ENSG00000187257
- Chromosome
- 7
- Canonical length
- 846 aa
- Protein class
- Cancer-related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Plasma membrane
OverviewNCBI Gene
Predicted to enable dioxygenase activity and metal ion binding activity. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
846 residues, UniProt reviewed canonical sequence.
>Q6PCB5|RSBN1L
1 MAEPPSPVHC VAAAAPTATV SEKEPFGKLQ LSSRDPPGSL SAKKVRTEEK KAPRRVNGEG
61 GSGGNSRQLQ PPAAPSPQSY GSPASWSFAP LSAAPSPSSS RSSFSFSAGT AVPSSASASL
121 SQPVPRKLLV PPTLLHAQPH HLLLPAAAAA ASANAKSRRP KEKREKERRR HGLGGAREAG
181 GASREENGEV KPLPRDKIKD KIKERDKEKE REKKKHKVMN EIKKENGEVK ILLKSGKEKP
241 KTNIEDLQIK KVKKKKKKKH KENEKRKRPK MYSKSIQTIC SGLLTDVEDQ AAKGILNDNI
301 KDYVGKNLDT KNYDSKIPEN SEFPFVSLKE PRVQNNLKRL DTLEFKQLIH IEHQPNGGAS
361 VIHAYSNELS HLSPMEMERF AEEFVGLVFS ENENSAAFYV MGIVHGAATY LPDFLDYFSF
421 NFPNSPVKME ILGKKDIETT TMSNFHAQVK RTYSHGTYRA GPMRQISLVG AVDEEVGDYF
481 PEFLDMLEES PFLKCTLPWG TLSSLKLQSR KDSDDGPIMW VRPGEQMIPV ADMPKSPFKR
541 KRTTNEIKNL QYLPRTSEPR EMLFEDRTRA HADHIGQGFE RQTTAAVGVL KAVHCGEWPD
601 QPRITKDVIC FHAEDFLEVV QRMQLDLHEP PLSQCVQWVD DAKLNQLRRE GIRYARIQLY
661 DNDIYFIPRN VVHQFKTVSA VCSLAWHIRL KLYHSEEDTS QNTATHETGT SSDSTSSVLG
721 PHTDNMICAV SKASLDSVFS DKLHSKYELQ QIKHEPIASV RIKEEPVNVN IPEKTTALNN
781 MDGKNVKAKL DHVQFAEFKI DMDSKFENSN KDLKEELCPG NLSLVDTRQH SSAHSNQDKK
841 DDDILCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RSBN1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- retina: 28 nTPM
- testis: 25 nTPM
- thymus: 17 nTPM
- thyroid gland: 16 nTPM
- lymph node: 15 nTPM
- spleen: 14 nTPM
Single-cell type
- neutrophils: 399 nCPM
- early spermatids: 339 nCPM
- rod photoreceptor cells: 310 nCPM
- retinal bipolar cells: 231 nCPM
- cone photoreceptor cells: 230 nCPM
- neutrophil progenitors: 206 nCPM
Immune cell
- neutrophil: 55 nTPM
- basophil: 18 nTPM
- plasmacytoid DC: 13 nTPM
- naive B-cell: 12 nTPM
- eosinophil: 11 nTPM
- memory B-cell: 9.8 nTPM
Brain region
- cerebellum: 41 nTPM
- white matter: 26 nTPM
- hypothalamus: 23 nTPM
- choroid plexus: 23 nTPM
- cerebral cortex: 22 nTPM
- spinal cord: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RSBN1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RSBN1L as an antibody target. Whether an autoantibody or antibody against RSBN1L could matter depends on whether native RSBN1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RSBN1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RSBN1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...